OpenBIO® modernized legacy bioreactor systems—cutting costs, minimizing downtime & ensuring compliance.

A biopharma company modernized with OpenBIO bioreactor controls, boosting cell culture runs by 70%.

Catalyx led a GMP-compliant DeltaV Live migration, modernizing HMI, upgrading alarm management and future-proofing process control for life sciences operations.

A biopharmaceutical manufacturer implemented OpenEMS, improving compliance and operational efficiency.

A biometric monitoring device manufacturer faced challenges in managing high-speed, multi-site assembly and packaging. 

Faced with increasing operational inefficiencies and rising labor costs, a large-scale logistics network sought to optimize fulfillment and sortation processes across North America. 

In the beauty industry, flawless presentation is everything

Catalyx boosted efficiency at a Cell and Gene Therapy company by building a skilled local engineering team.

Catalyx's Functional Service Provision model transformed a biopharma company's workforce.

With Catalyx’s integrated serialization and warehouse solution, the client met all Korean market compliance requirements.

A pharma company reduced contamination risks and batch time with OpenBIO Bioreactor Controllers and Endress+Hauser’s Raman analyzers, 

A life sciences manufacturer saved time on batch reconciliation with the OpenStation Vial & Syringe Counter.